C

    CryoCell International Inc (CCEL)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • AMEX

    $4.13
    +0.13 (+3.25%)

    Market Cap: $33.86M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    83%(19/23)
    Avg Surprise
    -24.14%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Aug 31, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.12-500.0%
    60d ago$-0.12-500.0%
    30d ago$0.07+133.3%
    7d ago$0.07+133.3%
    Current$0.03
    Revenue Consensus
    $7M
    Range$7M - $7M
    1 analysts
    Period ending Nov 30, 2026
    EPS Consensus$0.10
    Range$0.10 - $0.10
    1 analysts
    Revenue Consensus
    $7M
    Range$7M - $7M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Nov 26EST
    		-$0.10---
    Aug 26EST
    		-$0.03---
    May 26
    Reported Jul 15
    		$0.07$0.00N/ABeat+40.0%
    Feb 26
    Reported Apr 14
    		$0.02$-0.02+200.00%Beat-60.0%
    Nov 25
    Reported Feb 27
    		$-0.47$-0.03-1452.00%Miss-82.9%
    Aug 25
    Reported Oct 15
    		$0.10$-0.03+433.33%Beat-28.6%
    May 25
    Reported Jul 15
    		$0.05$-0.04+225.00%Beat-50.0%
    Feb 25
    Reported Apr 14
    		$0.05$0.01+400.00%Beat-44.4%
    Nov 24
    Reported Feb 26
    		$-0.25$0.02-1372.50%Miss+81.0%
    Aug 24
    Reported Oct 15
    		$0.14$0.03+366.67%Beat+55.6%
    May 24
    Reported Jul 15
    		$0.10$0.05+100.00%Beat+400.0%
    Feb 24
    Reported Apr 15
    		$0.09$-0.01+1000.00%Beat+12.5%
    Nov 23
    Reported Feb 28
    		$-1.34$-0.07-1814.29%Miss-1440.0%
    Aug 23
    Reported Oct 12
    		$0.09$-0.05+280.00%Beat+80.0%
    May 23
    Reported Jul 14
    		$0.02N/A+128.57%Beat-75.0%
    Feb 23
    Reported Apr 21
    		$0.08$-0.03+366.67%Beat-20.0%
    Nov 22
    Reported Feb 28
    		$0.10$-0.02+600.00%Beat+242.9%
    Aug 22
    Reported Oct 14
    		$0.05$0.06-16.67%Miss-50.0%
    May 22
    Reported Jul 11
    		$0.08$0.08+0.00%Beat-42.9%
    Feb 22
    Reported Apr 13
    		$0.10N/AN/ABeat+25.0%
    Nov 21
    Reported Feb 22
    		$-0.07N/AN/ABeat-146.7%
    Aug 21
    Reported Oct 15
    		$0.10N/AN/ABeat+0.0%
    May 21
    Reported Jul 15
    		$0.14$0.14+0.00%Beat+16.7%
    Feb 21
    Reported Apr 14
    		$0.08$0.08+0.00%Beat+0.0%
    Nov 20
    Reported Feb 24
    		$0.15$0.15+0.00%Beat+117.4%
    Aug 20
    Reported Oct 15
    		$0.10$0.10+0.00%Beat-23.1%
    May 20
    Reported Jul 10
    		$0.12$0.12+0.00%Beat+1100.0%
    Feb 20
    Reported Apr 14
    		$0.08$0.08+0.00%Beat+166.7%
    Nov 19
    Reported Feb 27
    		$-0.86N/AN/ABeat-761.5%
    Aug 19
    Reported Oct 15
    		$0.13$0.13+0.00%Beat+333.3%
    May 19
    Reported Jul 15
    		$0.01N/AN/ABeat-85.7%
    Feb 19
    Reported Apr 15
    		$0.03N/AN/ABeat+109.1%
    Nov 18
    Reported Feb 28
    		$0.13$0.00N/ABeat-72.9%
    Aug 18
    Reported Oct 15
    		$0.03N/AN/ABeat-62.5%
    May 18
    Reported Jul 16
    		$0.07N/AN/ABeat+16.7%
    Feb 18
    Reported Apr 16
    		$-0.33N/AN/ABeat-571.4%
    Nov 17
    Reported Feb 28
    		$0.48$0.00N/ABeat+585.7%
    Aug 17
    Reported Oct 16
    		$0.08N/AN/ABeat-
    May 17
    Reported Jul 7
    		$0.06N/AN/ABeat-
    Feb 17
    Reported Apr 14
    		$0.07N/AN/ABeat-
    Nov 16
    Reported Feb 28
    		$0.07$0.00N/ABeat-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    Frequency4

    Key Metrics

    Valuation
    P/E Ratio-14.99EV/EBITDA53.47x
    Price/FCF5.45xFCF Yield18.36%
    Profitability
    Profit Margin-7.92%Operating Margin15.40%
    ROE129.20%ROIC-52.52%
    Financial Health
    Debt/Equity-0.52xInterest Coverage2.50x
    Current Ratio0.71xQuick Ratio0.69x
    Trading Statistics
    Beta0.52Avg Volume47.57K
    52-Week High$5.0052-Week Low$2.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.20
    SMA 20$3.94
    SMA 50$3.66
    SMA 200$3.57
    EMA 10$4.13
    EMA 20$3.99
    EMA 50$3.77
    EMA 200$3.83

    MACD

    Line: 0.18Signal: 0.18Hist: 0.00

    ADX

    ADX: 30.9+DI: 22.6-DI: 13.4

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down48.0
    PSAR$3.90

    Bollinger Bands

    Upper Band$4.58
    Lower Band$3.31
    %B Position3234%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    56.7

    Momentum Oscillators

    Stoch %K55.9
    Stoch %D59.3
    Williams %R-43.5
    ROC (10d)11.6%
    Momentum0.43
    CCI (20d)36.2
    MFI (14d)86.4

    Volatility Measures

    ATR (14d)$0.34(8.3%)
    StdDev (20d)0.32
    Hist Vol69.2%(High)

    Volume Flow

    VWAP$4.10
    OBV781.6K
    AD Line-1472833803.4B
    CMF (20d)0.251

    Volume Metrics

    Avg Vol (20d)49.6K
    Vol Ratio0.2x(Low)
    VWMA (20d)$3.95

    Pivot Points

    R3$4.68
    R2$4.55
    R1$4.27
    Pivot Point$4.14
    S1$3.86
    S2$3.73
    S3$3.45

    Advanced Oscillators

    TSI21.35
    Ultimate Osc41.9
    KST196.81

    Financial Data

    QuarterMay 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024Nov 2023Aug 2023
    Total Revenue$7.78M$7.68M$7.84M$7.83M$7.93M$7.97M$8.02M$8.07M$8.04M$7.85M$7.88M$7.87M
    Cost of Revenue$1.68M$1.66M$1.73M$1.80M$1.86M$1.98M$1.73M$2.13M$2.02M$2.07M$2.02M$2.16M
    Gross Profit$6.10M$6.03M$6.11M$6.02M$6.07M$5.98M$6.29M$5.94M$6.02M$5.79M$5.85M$5.71M
    Operating Expenses$4.90M$5.26M$10.08M$4.12M$4.58M$4.93M$6.42M$4.55M$4.63M$4.96M$22.03M$4.55M
    R&D$99,781$65,761$84,784$61,625$131,711$98,143$304,629$193,933$241,085$502,889$443,808$344,132
    SG&A$4.62M$5.01M$5.45M$3.88M$4.26M$4.64M$5.92M$4.16M$4.02M$4.43M$5.44M$3.80M
    Operating Income$1.20M$765,134$-3,966,787$1.90M$1.49M$1.06M$-122,347$1.39M$1.39M$821,223$-16,176,145$1.16M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$441,917$462,709$481,949$538,219$551,126$494,962$745,488$533,464$329,273$256,459$-169,031$469,642
    Income Before Tax$827,781$70,309$-4,631,970$1.19M$575,103$533,718$-842,434$1.38M$1.47M$794,510$-15,993,058$1.07M
    Income Tax Expense$273,195$23,201$-814,537$436,588$219,318$250,863$1.02M$328,186$816,390$238,269$-4,803,040$387,060
    Net Income$554,586$47,108$-3,817,433$749,408$355,785$282,855$-1,861,615$1.05M$655,790$556,241$-11,190,018$680,561
    EBITDA$1.62M$880,153$-3,814,623$2.08M$1.48M$1.37M$247,772$2.25M$2.00M$1.22M$-15,746,807$1.96M
    EBIT$1.27M$533,018$-4,150,021$1.72M$1.13M$1.03M$-96,946$1.91M$1.80M$1.05M$-16,162,089$1.54M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CCEL

    News

    Cryo-Cell International (CCEL) moves 600,191 shares to new 2026 trust

    Cryo-Cell International's Co-CEO, David Portnoy, transferred 600,191 common shares to the newly established David Portnoy Irrevocable 2026 Trust Agreement on August 5, 2026. The trust borrowed $800,000.26 to satisfy Portnoy's indebtedness, with Portnoy personally guaranteeing the repayment. After this restructuring, Portnoy directly holds 247,438 shares and maintains several indirect positions and stock options.

    Stock Titan•8/7/26•
    Neutral

    Cryo-Cell International, Inc. Revenue Breakdown – AMEX:CCEL

    Cryo-Cell International, Inc. (AMEX: CCEL) generated $31.60 million USD in revenue last year. The primary segment contributing to this revenue was Umbilical Cord Blood and Cord Tissue Stem Cell Service, accounting for $31.38 million USD. The majority of the company's revenue, $31.57 million USD, came from the United States.

    TradingView•8/1/26•
    Neutral

    Cryo-Cell International Inc (CCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk

    This article provides a risk assessment for Cryo-Cell International Inc (CCEL), noting its risk score of 2.80 and ranking within the Healthcare Providers & Services industry. It details the company's beta value of 0.49, indicating lower volatility compared to the S&P 500, and includes various metrics such as VaR, maximum drawdown, volatility, return rates, Sharpe Ratio, and liquidity indicators. The analysis suggests CCEL tends to have smaller declines in down markets but also underperforms in up markets.

    TradingKey•7/30/26•
    Somewhat-Bearish

    Cryo-Cell International Inc (CCEL) Valuation: PE, PB & Fair Value Analysis

    Cryo-Cell International Inc (CCEL) has an updated valuation score of 8.95, ranking 25th in the Healthcare Providers & Services industry. The company's current P/E ratio is -10.24, experiencing significant changes from its recent high and low. Data for P/B, P/S, and P/CF ratios have not yet been disclosed by the company.

    TradingKey•7/29/26•
    Neutral

    Cryo-Cell International Inc (CCEL) Financial Health: Profitability & Balance Sheet Analysis

    Cryo-Cell International Inc (CCEL) has a weak financial status and average operating efficiency, with a financial score of 7.22. The company's latest quarterly revenue decreased by 1.93% year-over-year, and its net profit saw a significant 55.88% year-over-year decline. Specific details on cash and cash equivalents, total assets, total liabilities, free cash flow, quality of earnings, and growth potential were not yet disclosed by the company.

    TradingKey•7/28/26•
    Bearish

    Frequently Asked Questions About CCEL

    Does CCEL pay dividends?
    CryoCell International Inc (CCEL) has a dividend payment track record. See the CCEL dividend history page for its current payment status, yield, and streaks.
    What is CCEL's market cap?
    CryoCell International Inc (CCEL) has a market capitalization of $33.86M with a current stock price of $4.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In